{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T23:27:59Z","timestamp":1781134079565,"version":"3.54.1"},"update-to":[{"DOI":"10.1002\/14651858.cd003940.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2010,11,10]],"date-time":"2010-11-10T00:00:00Z","timestamp":1289347200000}}],"reference-count":108,"publisher":"Wiley","issue":"11","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003940.pub3","type":"journal-article","created":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T18:36:48Z","timestamp":1288636608000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children"],"prefix":"10.1002","volume":"2010","author":[{"given":"Elizabeth D","family":"Pienaar","sequence":"first","affiliation":[{"name":"Medical Research Council; South African Cochrane Centre; PO Box 19070 Tygerberg South Africa 7505"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taryn","family":"Young","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences; Division of Community Health; University of Stellenbosch PO Box 19063 Tygerberg South Africa 7505"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haly","family":"Holmes","sequence":"additional","affiliation":[{"name":"University of the Western Cape; Oral Health Centre; Private Bag X08 Mitchell's Plain Cape Town South Africa 7789"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,11,10]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD003940.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1128\/AAC.46.2.451-457.2002","article-title":"Randomized, double-blind, multicenter study of caspofungin versus amphotericin B for treatment of oropharyngeal and esophageal candidiasis","volume":"46","author":"Arathoon","year":"2002 Feb","journal-title":"Antimicrobial Agents & Chemotherapy"},{"issue":"17","key":"10.1002\/14651858.CD003940.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1136\/bmj.305.6859.921","article-title":"Trial of glucose versus fat emulsion in preparation of amphotericin for use in HIV-infected patients with candidiasis","volume":"305","author":"Chavanet","year":"1992","journal-title":"British Medical Journal"},{"issue":"5","key":"10.1002\/14651858.CD003940.pub3-BIB0003|cit3","first-page":"374","article-title":"Comparison of itraconazole and ketoconazole in HIV-positive patients with oropharyngeal or esophageal candidiasis. Human Immunodeficiency Virus Itraconazole Ketoconazole Project Group.","volume":"42","author":"Repentigny","year":"1996","journal-title":"Chemotherapy"},{"issue":"8641","key":"10.1002\/14651858.CD003940.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0140-6736(89)92572-5","article-title":"Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS","volume":"1","author":"Wit","year":"1989","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003940.pub3-BIB0005|cit5","doi-asserted-by":"crossref","unstructured":"De Wit S Goossens H Clumeck N Single-dose versus 7 days of fluconazole treatment for oral candidiasis in human immunodeficiency virus-infected patients: A prospective,randomized pilot study Journal of Infectious Diseases 1993 1332 3","DOI":"10.1093\/infdis\/168.5.1332"},{"issue":"6","key":"10.1002\/14651858.CD003940.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/00002030-199706000-00009","article-title":"A dose comparison study of a new triazole antifungal (D0870) in HIV-positive patients with oral candidiasis.","volume":"11","author":"Wit","year":"1997","journal-title":"AIDS"},{"issue":"3","key":"10.1002\/14651858.CD003940.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/030006059802600307","article-title":"Safety and efficacy of single-dose fluconazole compared with a 7-day regimen of itraconazole in the treatment of AIDS-related oropharyngeal candidiasis","volume":"26","author":"Wit","year":"1998","journal-title":"Journal of International Medical Research"},{"issue":"5","key":"10.1002\/14651858.CD003940.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1093\/infdis\/168.5.1332","article-title":"Single-dose versus 7 days of fluconazole treatment for oral candidiasis in human immunodeficiency virus-infected patients: A prospective, randomized study","volume":"168","author":"Wit","year":"1993","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD003940.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1086\/497373","article-title":"A randomized study for the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group STudy 323 \/ Mycoses Study Group Study 40","volume":"41","author":"Goldman","year":"2005","journal-title":"Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD003940.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0002-9343(97)00307-0","article-title":"Randomized trial of itraconazole oral solution for oropharyngeal candidiasis in HIV\/AIDS patients","volume":"104","author":"Graybill","year":"1998","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD003940.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0002-9343(97)00307-0","article-title":"Randomized trial of itraconazole oral solution for oropharyngeal candidiasis in HIV\/AIDS patients","volume":"104","author":"Graybill","year":"1998","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD003940.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1086\/592578","article-title":"Single-dose fluconazole versus 2-week therapy for oropharyngeal Candidiasis in HIV-infected Patiens: A randomized, double-blind, double-dummy trial","volume":"47","author":"Hamza","year":"2008","journal-title":"Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD003940.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/BF01974616","article-title":"Fluconazole versus Ketoconazole in the treatment of oropharyngeal candidiasis in HIV-infected children","volume":"13","author":"Hernandez-Sampelayo","year":"1994","journal-title":"European Journal of Clinical Microbiology and Infectious Diseases"},{"issue":"11","key":"10.1002\/14651858.CD003940.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/BF02005444","article-title":"Fluconazole prophylaxis of recurrent oral candidiasis in HIV -positive patients","volume":"10","author":"Just-Nubling","year":"1991","journal-title":"European Journal of Clinical Microbiology and Infectious Diseases"},{"issue":"11","key":"10.1002\/14651858.CD003940.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/BF02005444","article-title":"Fluconazole prophylaxis of recurrent oral candidiasis in HIV -positive patients","volume":"10","author":"Just-Nubling","year":"1991","journal-title":"European Journal of Clinical Microbiology and Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD003940.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0163-4453(90)90646-P","article-title":"Once-weekly fluconazole to prevent recurrence of oropharyngeal candidiasis in patients with AIDS and AIDS-related complex: a double-blind placebo-controlled study. [erratum appears in J Infect 1990 Sep;21(2):183.]","volume":"21","author":"Leen","year":"1990 Jul","journal-title":"Journal of Infection"},{"issue":"11","key":"10.1002\/14651858.CD003940.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1046\/j.1365-4362.2000.00087.x","article-title":"Clinical trial: clotrimazole troche vs. itraconazole oral solution in the treatment of oral candidosis in AIDS patients","volume":"39","author":"Linpiyawan","year":"2000 Nov","journal-title":"International Journal of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD003940.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/00042560-199608150-00005","article-title":"Prophylaxis with nystatin pastilles for HIV associated oral candidiasis","volume":"12","author":"MacPhail","year":"1996","journal-title":"Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology"},{"issue":"4","key":"10.1002\/14651858.CD003940.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/00042560-199608150-00005","article-title":"Prophylaxis with nystatin pastilles for HIV associated oral candidiasis","volume":"12","author":"MacPhail","year":"1996","journal-title":"Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology"},{"issue":"5","key":"10.1002\/14651858.CD003940.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"312","DOI":"10.5694\/j.1326-5377.1993.tb121784.x","article-title":"Fluconazole once a week as secondary prophylaxis against oropharyngeal candidiasis in HIV-infected patients. A double-blind placebo-controlled study","volume":"158","author":"Marriott","journal-title":"Medical Journal of Australia"},{"issue":"5","key":"10.1002\/14651858.CD003940.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1086\/514744","article-title":"Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study. National Institute of Allergy and Infectious Diseases Mycoses Study Group","volume":"28","author":"McKinsey","year":"1999 May","journal-title":"Clinical Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD003940.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0149-2918(97)80131-2","article-title":"Itraconazole oral solution versus Clotrimazole troches for the treatment or oropharyngeal Candidiasis in immunocompromised patients.","volume":"19","author":"Murray","year":"1997","journal-title":"Clinical Therapeutics"},{"key":"10.1002\/14651858.CD003940.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1601-0825.2008.01449.x","article-title":"A randomized clinical trial of chlorhexidine in the maintenance of oral candidiasis-free period in HIV infection","volume":"14","author":"Nittayananta","year":"2008","journal-title":"Oral Diseases"},{"issue":"1","key":"10.1002\/14651858.CD003940.pub3-BIB0024|cit24","first-page":"45","article-title":"Gentian violet, ketoconazole and nystatin in oropharyngeal and esophageal candidiasis in Zairian AIDS patients.","volume":"72","author":"Nyst","year":"1992","journal-title":"Annales de la Societie Belge de Medecine Tropicale"},{"key":"10.1002\/14651858.CD003940.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/jac\/dkf101","article-title":"Efficacy, tolerability and development of resistance in HIV-positive patients treated with fluconazole for secondary prevention of oropharyngeal candidiasis: a randomized, double-blind, placebo-controlled trial","volume":"50","author":"Pagani","year":"2002","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD003940.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1086\/516342","article-title":"A double-blind comparison of itraconazole oral solution and fluconazole capsules for the treatment of oropharyngeal candidiasis in patients with AIDS","volume":"26","author":"Phillips","year":"1998","journal-title":"Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD003940.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1086\/516342","article-title":"A double-blind comparison of itraconazole oral solution and fluconazole capsules for the treatment of oropharyngeal candidiasis in patients with AIDS","volume":"26","author":"Phillips","year":"1998","journal-title":"Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD003940.pub3-BIB0028|cit28","unstructured":"Barbacci M Lichter S Palenicek J Chaisson RE Yamaguchi E Fluconazole or clotrimazole troche for oropharyngeal candidiasis in HIV-1 positive patients International Conference on AIDS 1990 218 (abstract no. TH.B.385)"},{"issue":"11","key":"10.1002\/14651858.CD003940.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1128\/AAC.34.11.2267","article-title":"Comparison of oral fluconazole and clotrimazole troches as treatment for oral candidiasis in patients infected with human immunodeficiency virus","volume":"34","author":"Koletar","year":"1990","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"12","key":"10.1002\/14651858.CD003940.pub3-BIB0030|cit30","first-page":"1311","article-title":"Therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, prospective multicenter study of oral fluconazole versus clotrimazole troches. The Multicenter Study Group. [see comments.]","volume":"6","author":"Pons","year":"1993 Dec","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"6","key":"10.1002\/14651858.CD003940.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1086\/513664","article-title":"Oropharyngeal candidiasis in patients with AIDS: Randomized comparison of fluconazole versus nystatin oral suspensions","volume":"24","author":"Pons","year":"1997","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD003940.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1754-4505.1992.tb00402.x","article-title":"A comparison between fluconazole tablets and clotrimazole troches for the treatment of thrush in HIV infection","volume":"12","author":"Redding","year":"1992","journal-title":"Special Care in Dentistry"},{"issue":"1","key":"10.1002\/14651858.CD003940.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0002-9343(98)00137-5","article-title":"A randomized trial of continuous or intermittent therapy with fluconazole for oropharyngeal candidiasis in HIV-infected patients: Clinical outcomes and development of fluconazole resistance","volume":"105","author":"Revankar","year":"1998","journal-title":"American Journal of Medicine"},{"issue":"9","key":"10.1002\/14651858.CD003940.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"689","DOI":"10.7326\/0003-4819-126-9-199705010-00003","article-title":"Weekly fluconazole for the prevention of mucosal candidiasis in women with HIV infection. A randomized, double-blind, placebo-controlled trial","volume":"126","author":"Schuman","year":"1997","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD003940.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1097\/00002030-199111000-00014","article-title":"Itraconazole versus ketaconazole in the treatment of oral oesophageal candidosis in patients infected with HIV.","volume":"5","author":"Smith","year":"1991","journal-title":"AIDS"},{"key":"10.1002\/14651858.CD003940.pub3-BIB0036|cit36","unstructured":"Lang OS Stevens DA Greene SI Thrush(T) can be prevented in AIDS\/ARC patients(pts): Randomized (R) double-blind placebo (P)-controlled study of 100mg fluconazole (F) daily. International Conference on AIDS 1990 395 (abstract no. 2165)"},{"issue":"12","key":"10.1002\/14651858.CD003940.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1001\/archinte.1991.00400120096018","article-title":"Thrush can be prevented in patients with acquired immunodeficiency syndrome and the acquired immunodeficiency syndrome-related complex. Randomized, double-blinded, placebo-controlled study of 100mg oral Fluconazole daily.","volume":"151","author":"Stevens","year":"1991","journal-title":"Archives of Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD003940.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/00126334-200402010-00007","article-title":"Comparative efficacy of topical therapy with a slow release mucoadhesive buccal tablet containing Miconazole nitrate versus systemic therapy with Ketoconazole in HIV-positive patients with oropharyngeal Candidiasis.","volume":"35","author":"Roey","year":"2004","journal-title":"Journal of Acquired Immune Deficiency Syndrome"},{"issue":"5","key":"10.1002\/14651858.CD003940.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1310\/hct.2002.3.5.005","article-title":"Efficacy of alcohol-based and alcohol-free melaleuca oral solution for the treatment of fluconazole-refractory oropharyngeal candidiasis in patients with AIDS","volume":"3","author":"Vazquez","year":"2002","journal-title":"HIV Clinical Trials"},{"key":"10.1002\/14651858.CD003940.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1086\/501457","article-title":"A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV\/AIDS","volume":"42","author":"Vazquez","year":"2006","journal-title":"Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD003940.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.phymed.2008.07.015","article-title":"Treatment of oral thrush in HIV\/AIDS patients with lemon juice and lemon grass (Cymbopogon citratus) and gentian violet","volume":"16","author":"Wright","year":"2009","journal-title":"Phytomedicine"},{"issue":"5","key":"10.1002\/14651858.CD003940.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1055\/s-2007-1005717","article-title":"Fluconazole vs. flucytosine in the treatment of esophageal candidiasis in AIDS patients: a double-blind, placebo-controlled study","volume":"27","author":"Barbaro","year":"1995 Jun","journal-title":"Endoscopy"},{"issue":"6","key":"10.1002\/14651858.CD003940.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3109\/00365549509047076","article-title":"Fluconazole compared with itraconazole in the treatment of esophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study","volume":"27","author":"Barbaro","year":"1995","journal-title":"Scandinavian Journal of Infectious Diseases"},{"issue":"44","key":"10.1002\/14651858.CD003940.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1080\/00016359850142790","article-title":"Fluconazole versus Nystatin in the treatment of oral candidosis.","volume":"56","author":"Blomgren","year":"1998","journal-title":"Acta Odontologica Scandinavica"},{"key":"10.1002\/14651858.CD003940.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/00002030-200005050-00011","article-title":"Amphotericin B oral suspension for fluconazole-refractory oral candidiasis in persons with HIV infection","volume":"14","author":"Fichtenbaum","year":"2000","journal-title":"AIDS"},{"issue":"2","key":"10.1002\/14651858.CD003940.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0022-3476(95)70321-7","article-title":"Oropharyngeal candidiasis in immunocompromised children: a randomized, multicenter study of orally administered fluconazole suspension versus nystatin. The Multicenter Fluconazole Study Group","volume":"127","author":"Flynn","year":"1995 Aug","journal-title":"Journal of Pediatrics"},{"issue":"9","key":"10.1002\/14651858.CD003940.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1097\/00002030-199809000-00011","article-title":"Efficacy of melaleuca oral solution for the treatment of fluconazole refractory oral candidiasis in AIDS patients","volume":"12","author":"Jandourek","year":"1998","journal-title":"AIDS"},{"key":"10.1002\/14651858.CD003940.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2036.1991.tb00021.x","article-title":"Fluconazole for oropharyngeal candidiasis in anti-HIV positive haemophiliacs.","volume":"5","author":"Lim","year":"1991","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"16","key":"10.1002\/14651858.CD003940.pub3-BIB0049|cit49","first-page":"2237","article-title":"Treatment of oral candidiasis: a study to determine the clinical response of sodium benzoate compared with nystatin suspension","volume":"12","author":"Moshi","year":"1998","journal-title":"AIDS"},{"issue":"5","key":"10.1002\/14651858.CD003940.pub3-BIB0050|cit50","first-page":"307","article-title":"Oropharyngeal candidiasis in AIDS patients from Abidjan (Ivory Coast): antifungal susceptibilities and multilocus enzyme electrophoresis analysis of Candida albican isolates","volume":"46","author":"Nebavi","year":"1998","journal-title":"Pathologie Biologie"},{"issue":"12","key":"10.1002\/14651858.CD003940.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1097\/00002030-199610000-00009","article-title":"Itraconazole cyclodextrin solution for fluconazole-refractory oropharyngeal candidiasis in AIDS: correlation of clinical response with in vitro suceptability","volume":"10","author":"Phillips","year":"1996","journal-title":"AIDS"},{"issue":"2","key":"10.1002\/14651858.CD003940.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/BF01739022","article-title":"Fluconazole therapy of oral candidiasis in HIV-infected patients: results of a multicentre study","volume":"22","author":"Plettenberg","year":"1994 Mar-Apr","journal-title":"Infection"},{"issue":"11","key":"10.1002\/14651858.CD003940.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1056\/NEJM199503163321102","article-title":"A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group. [see comments.]","volume":"332","author":"Powderly","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003940.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1086\/511039","article-title":"Posaconazole fot the treatment of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infection","volume":"44","author":"Skiest","year":"2007","journal-title":"Clinical Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD003940.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1046\/j.1468-1293.2001.00060.x","article-title":"A randomized, double-blind, placebo-controlled study of itraconazole capsules for the prevention of deep fungal infections in immunodeficient patients with HIV infection","volume":"2","author":"Smith","year":"2001 Apr","journal-title":"HIV Medicine"},{"key":"10.1002\/14651858.CD003940.pub3-BIB0056|cit56","unstructured":"Soubry R Banyangiliki V Clerinx J Vandepere P Taelman H Bogaert J Kagame A Batungwamayo J Comparison of itraconazole oral solution and fluconazole capsules in the treatment of oral and esophageal candidiasis in HIV-infected patients. Preliminary results Int Conf AIDS 1991 232 (Abstract no. M.B.2201)"},{"key":"10.1002\/14651858.CD003940.pub3-BIB0057|cit57","unstructured":"Uberti Foppa C Cernuschi M Esposito R Treatment of HIV+ patients with oropharyngeal and\/or oesophageal candidiasis: The results of a D.B. study. Int Conf AIDS 1989 474 (abstract no Th.B.P.348)"},{"issue":"8","key":"10.1002\/14651858.CD003940.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1089\/apc.2007.0160","article-title":"Antifungal effect of mouth rinses on oral Candida counts and salivary flow in treatment-na\u00efve HIV-infected patients","volume":"22","author":"Patel","year":"2008","journal-title":"AIDS Patient Care and STDs"},{"key":"10.1002\/14651858.CD003940.pub3-BIB0059|cit59","unstructured":"A randomized multicenter study of the efficacy, safety, and toleration of Fluconazole or Clotrimazole troches in the treatment of patients with oropharyngeal candidiasis in association with the acquired immunodeficiency syndrome http:\/\/ClinicalTrials.gov"},{"key":"10.1002\/14651858.CD003940.pub3-BIB0060|cit60","unstructured":"An open study of the effect of Itraconazole oral solution for the treatment of fluconazole refractory oropharyngeal candidiasis in HIV-positive subjects. http:\/\/ClinicalTrials.gov"},{"key":"10.1002\/14651858.CD003940.pub3-BIB0061|cit61","unstructured":"A multicenter, randomized, double-blind, phase II study to evaluate the safety, tolerance and efficacy of multiple doses of SCH 56592 versus fluconazole in the treatment of oropharyngeal candidiasis (OPC) in HIV-positive patients. http:\/\/ClinicalTrials.gov"},{"key":"10.1002\/14651858.CD003940.pub3-BIB0062|cit62","unstructured":"Randomized controlled trial of SCH 56592 oral suspension versu fluconazole suspension in the treatment of orophryngeal candidiasis (OPC) in HIV-positive patients http:\/\/ClinicalTrials.gov"},{"key":"10.1002\/14651858.CD003940.pub3-BIB0063|cit63","article-title":"Cochrane Reviewers' Handbook 4.2.2 (updated March 2004)","volume-title":"The Cochrane Library, Issue 3, 2004","author":"Alderson","year":"2004"},{"issue":"7057","key":"10.1002\/14651858.CD003940.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1136\/bmj.313.7057.570","article-title":"Better reporting of randomised controlled trials: the CONSORT statement (editorial)","volume":"313","author":"Altman","year":"1996","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD003940.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1600-0714.1998.tb01936.x","article-title":"Oral manifestations of HIV infection in 600 South African patients","volume":"27","author":"Arendorf","year":"1998 Apr","journal-title":"J Oral Pathol Med"},{"issue":"8","key":"10.1002\/14651858.CD003940.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/00002030-200005260-00009","article-title":"Impact of protease inhibitor therapy on HIV-related oropharyngeal candidiasis","volume":"14","author":"Arribas","year":"2000","journal-title":"AIDS"},{"key":"10.1002\/14651858.CD003940.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1574-695X.2001.tb01588.x","article-title":"HIV protease inhibitors attenuate adherence of Candida albicans to epithelial cells in vitro","volume":"31","author":"Bektic","year":"2001","journal-title":"FEMS Immunology and Medical Microbiology"},{"issue":"4","key":"10.1002\/14651858.CD003940.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/00002030-199804000-00010","article-title":"Treatment of HIV-related fluconazole-resistant oral candidosis with D0870, a new triazole antifungal","volume":"12","author":"Cartledge","year":"1998","journal-title":"AIDS"},{"key":"10.1002\/14651858.CD003940.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1086\/314871","article-title":"In vitro and in vivo anticandidal activity of human immunodeficiency virus protease inhibitors","volume":"180","author":"Cassone","year":"1999","journal-title":"Journal of Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD003940.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/00126334-199905010-00003","article-title":"Role of protease inhibitors in preventing recurrent oral Candidosis in patients with HIV infection: A prospective case-control study","volume":"21","author":"Cauda","year":"1999","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1002\/14651858.CD003940.pub3-BIB0071|cit71","unstructured":"Centres for Disease Control 1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS among Adolescents and Adults Mortality and Morbidity Weekly Report 1 19"},{"issue":"RR-10","key":"10.1002\/14651858.CD003940.pub3-BIB0072|cit72","first-page":"1-59; 61-6","article-title":"1999 USPHS\/IDSA Guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus:U.S. Public Health Service (USPHS) and Infectious Diseases Society of America(IDSA)","volume":"48","author":"Centers for Disease Control and Prevention","year":"1999","journal-title":"MMWR Morbidity and Mortality weekly Report"},{"issue":"9","key":"10.1002\/14651858.CD003940.pub3-BIB0073|cit73","first-page":"700","article-title":"Oral lesions in infection with human immunodeficiency virus","volume":"83","author":"Coogan","year":"2005","journal-title":"Bulletin of the World Health Organization"},{"issue":"4","key":"10.1002\/14651858.CD003940.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1128\/AAC.42.4.903","article-title":"Pharmacokinetics of two multiple-dosing regimens of D0870 in human immunodeficiency virsu-positive patients: a Phase I study","volume":"42","author":"Wit","year":"1998","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1002\/14651858.CD003940.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0149-2918(98)80033-7","article-title":"Oropharyngeal candidiasis: A review of its clinical spectrum and current therapies","volume":"20","author":"Epstein","year":"1998","journal-title":"Clinical Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD003940.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1001\/jama.279.2.130","article-title":"The cost-effectiveness of preventing AIDS-related opportunistic infections","volume":"279","author":"Freedberg","year":"1998","journal-title":"JAMA"},{"issue":"11","key":"10.1002\/14651858.CD003940.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"932","DOI":"10.7326\/0003-4819-120-11-199406010-00006","article-title":"Prophylaxis for opportunistic infections in patients with HIV infection","volume":"120","author":"Gallant","year":"1994","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD003940.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/01.NMC.0000305658.32237.7d","article-title":"Oral health & HIV\/AIDS","volume":"33","author":"Gennaro","year":"2008","journal-title":"MCN American Journal of Maternal and Child Nursing"},{"issue":"1","key":"10.1002\/14651858.CD003940.pub3-BIB0079|cit79","article-title":"Nystatin prophylaxis and treatment in severely immunodepressed patients","author":"Gotzsche","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD003940.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/0030-4220(92)90185-S","article-title":"Oral manifestations of HIV Infection. Definitions, diagnostic criteria and principles of therapy.","volume":"73","author":"Greenspan","year":"1992","journal-title":"Oral Surg Oral Med Oral Pathol"},{"issue":"2","key":"10.1002\/14651858.CD003940.pub3-BIB0081|cit81","first-page":"100","article-title":"Taste and smell. Neglected senses that contribute to the malnutrition of AIDS","volume":"58","author":"Healtd","year":"1997 Mar-Apr","journal-title":"North Carolina Medical Journal"},{"key":"10.1002\/14651858.CD003940.pub3-BIB0082|cit82","doi-asserted-by":"crossref","DOI":"10.1002\/9780470712184.ch8","article-title":"Chapter 8: Assessing risk of bias in included studies","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2008"},{"key":"10.1002\/14651858.CD003940.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/154407370601900112","article-title":"Oral lesion of HIV disease and HAART in industralized countries","volume":"19","author":"Hodgson","year":"2006","journal-title":"Advances in Dental Research"},{"issue":"5","key":"10.1002\/14651858.CD003940.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S1079-2104(98)90291-8","article-title":"Fluconazole-resistant Candida species in the oral flora of fluconazole-exposed HIV-positive patients.","volume":"85","author":"Hunter","year":"1998","journal-title":"Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics"},{"key":"10.1002\/14651858.CD003940.pub3-BIB0085|cit85","first-page":"832","article-title":"HIV: prevention of opportunistic infections","volume-title":"Clinical Evidence. Issue 14","author":"Ioannidis","year":"2005"},{"key":"10.1002\/14651858.CD003940.pub3-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJM198408093110602","article-title":"Oral candidiasis in high risk patients as the initial manifestation of the acquired immunodeficiency syndrome","volume":"311","author":"Klein","year":"1984","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003940.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1086\/501465","article-title":"Oropharyngeal Candidiasis: A new treatment option","volume":"42","author":"Klotz","year":"2006","journal-title":"Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD003940.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/jac\/44.4.429","article-title":"The use of fluconazole and itraconazole in the treatment of Candida albicans infections: a review","volume":"44","author":"Martin","year":"1999","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"15","key":"10.1002\/14651858.CD003940.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1001\/jama.285.15.1987","article-title":"The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials","volume":"285","author":"Moher","year":"1987","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD003940.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0966-842X(02)02330-2","article-title":"Antifungal therapy at the HAART of antiviral therapy.","volume":"10","author":"Munro","year":"2002 Apr","journal-title":"Trends Microbiol"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003940.pub3-BIB0091|cit91","first-page":"41","article-title":"Oral lesions in a group of Thai people with AIDS","volume":"3","author":"Nittayananta","year":"1997","journal-title":"Oral Diseases"},{"key":"10.1002\/14651858.CD003940.pub3-BIB0092|cit92","unstructured":"Osmond DH Classification, Staging, and Surveillance of HIV Disease The AIDS knowledge base http:\/\/hivinsite.ucsf.edu\/akb\/1997\/01class 1998"},{"issue":"9","key":"10.1002\/14651858.CD003940.pub3-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.ejca.2004.03.003","article-title":"An open multicentre comparatives study of the efficacy, safety and tolerance of fluconazole and itraconazole in the treatment of cancer patients with oropharyngeal candidiasis","volume":"40","author":"Oude Lashof","year":"2004","journal-title":"European Journal of Cancer"},{"issue":"5","key":"10.1002\/14651858.CD003940.pub3-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1079\/BJN20041264","article-title":"Oral candidiasis and nutritional deficiencies in elderly hospitalised patients","volume":"92","author":"Paillaud","year":"2004 Nov","journal-title":"British Journal of Nutrition"},{"key":"10.1002\/14651858.CD003940.pub3-BIB0095|cit95","first-page":"1","article-title":"Candidiasis (oropharyngeal)","volume-title":"Clinical Evidence. Issue 14","author":"Pankhurst","year":"2005"},{"key":"10.1002\/14651858.CD003940.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1067\/moe.2001.116600","article-title":"A systematic review of the effectiveness of antifungal drugs for the prevention and treatment of oropharyngeal candidiasis in HIV-positive patients","volume":"92","author":"Patton","year":"2001","journal-title":"Oral Surgery, Oral Medicine, Orla Pathology, Oral Radiology and Endodontics"},{"key":"10.1002\/14651858.CD003940.pub3-BIB0097|cit97","first-page":"27","article-title":"Looking into the mouth - oral manifestations of HIV infection","volume":"5","author":"Rachanis","year":"2001 Aug","journal-title":"South African Journal of HIV Medicine"},{"issue":"2","key":"10.1002\/14651858.CD003940.pub3-BIB0098|cit98","first-page":"85","article-title":"Classification, diagnostic criteria, and treatment recommendations for orofacial manifestations in HIV-infected pediatric patients. Collaborative Workgroup on Oral Manifestations of Pediatric HIV Infection.","volume":"23","author":"Ramos-Gomez","year":"1999 Winter","journal-title":"Journal of Clinical Pediatric Dentistry"},{"key":"10.1002\/14651858.CD003940.pub3-BIB0099|cit99","unstructured":"Ramsay C How do you include trials with more than two groups into a single meta-analysis? http:\/\/www.epoc.uottawa.ca\/FAQmultiplegroups2003.pdf 2003"},{"key":"10.1002\/14651858.CD003940.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1086\/313749","article-title":"Practice Guideline for the Treatment of Candidiasis","volume":"30","author":"Rex","year":"2000","journal-title":"Clinical Infectious diseases"},{"issue":"5","key":"10.1002\/14651858.CD003940.pub3-BIB0101|cit101","first-page":"143","article-title":"Oral manifestations of HIV disease","volume":"13","author":"Reznik","journal-title":"Topics in HIV Medicine"},{"key":"10.1002\/14651858.CD003940.pub3-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1600-0714.1986.tb00646.x","article-title":"A comparison of oral rinse and imprint sampling techniques for the detection of yeast, coliform and Staphilococcus aureus damage in the oral cavity","volume":"15","author":"Samaranayake","year":"1986","journal-title":"Journal of Oral Pathology"},{"key":"10.1002\/14651858.CD003940.pub3-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1034\/j.1600-0714.2000.290708.x","article-title":"Decline in the rate of oral opportunistic infections following introduction of highly active antiretroviral therapy","volume":"29","author":"Schmidt-Westhausen","year":"2000","journal-title":"J Oral Pathol Med"},{"key":"10.1002\/14651858.CD003940.pub3-BIB0104|cit104","first-page":"60","article-title":"In vitro susceptibilities of Candida and aspergillus species to Melaleuca alternifolia (tea tree) oil","volume":"17","author":"Vazquez","year":"2000","journal-title":"Revista Iberoamericana de Micologia"},{"key":"10.1002\/14651858.CD003940.pub3-BIB0105|cit105","first-page":"221","article-title":"Interim proposal for a WHO staging system for HIV infection and diseases","volume":"65","author":"World Health Organisation","year":"1993","journal-title":"Weekly Epidemiological Record"},{"issue":"7","key":"10.1002\/14651858.CD003940.pub3-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1600-0714.1993.tb01074.x","article-title":"Classification and diagnostic criteria for oral lesions in HIV infection","volume":"22","author":"Williams DM for EC-Clearinghouse on Oral Problems Related to HIV Infection and WHO Collaborating Centre on Oral Manifestations of the Immunodeficiency Virus","year":"1993","journal-title":"Journal of Oral Pathology and Medicine"},{"issue":"11","key":"10.1002\/14651858.CD003940.pub3-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1128\/AAC.37.11.2412","article-title":"In Vitro and In Vivo Antifungal Activities of D0870, a new triazole agent","volume":"37","author":"Yamada","year":"1993","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"6","key":"10.1002\/14651858.CD003940.pub3-BIB0108|cit108","first-page":"8","article-title":"Effect of prolonged HAART on oral colonization with Candida and candidiasis","volume":"20","author":"Yang","year":"2006","journal-title":"BMC Infect Dis. 2006 Jan 20;6:8."}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD003940.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T08:47:08Z","timestamp":1780994828000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD003940.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane HIV\/AIDS Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2010,11,10]]},"references-count":108,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2010,11]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003940.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,10]]}}}